Ekso Bionics Holdings (EKSO) Change in Account Payables (2016 - 2026)
Ekso Bionics Holdings has reported Change in Account Payables over the past 13 years, most recently at -$232000.0 for Q4 2025.
- On a quarterly basis, Change in Account Payables rose 6.07% to -$232000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$137000.0, a 52.43% increase, with the full-year FY2025 number at -$137000.0, up 52.43% from a year prior.
- Change in Account Payables reached -$232000.0 in Q4 2025 per EKSO's latest filing, down from $216000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.8 million in Q4 2021, with the low at -$882000.0 in Q2 2022.
- The 5-year median for Change in Account Payables is -$113000.0 (2021), against an average of -$11100.0.
- The largest YoY upside for Change in Account Payables was 1287.5% in 2025 against a maximum downside of 326.91% in 2025.
- Tracing EKSO's Change in Account Payables over 5 years: stood at $1.8 million in 2021, then plummeted by 66.57% to $602000.0 in 2022, then plummeted by 209.63% to -$660000.0 in 2023, then skyrocketed by 62.58% to -$247000.0 in 2024, then grew by 6.07% to -$232000.0 in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods came in at -$232000.0, $216000.0, and -$565000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.